CAR- T as well as mobile gene therapies are too expensive
.Mother Nature Medicine, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care production and technology transactions can provide cellular genetics treatments at a budget friendly cost to clients throughout the world.